TY - JOUR
T1 - Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario
AU - Mahar, A. L.
AU - El-Sedfy, A.
AU - Dixon, M.
AU - Siddiqui, M.
AU - Elmi, M.
AU - Ritter, A.
AU - Vasilevska-Ristovska, J.
AU - Jeong, Y.
AU - Helyer, L.
AU - Law, C.
AU - Zagorski, B.
AU - Coburn, Natalie G.
N1 - Funding Information:
This research was funded by a Canadian Cancer Society grant (no. 019325). NGC has received funding (Career Scientist Award) through the Ontario Ministry of Health and Long-Term Care (mohltc) and is supported by the Hanna Family Research Chair in Surgical Oncology. This study was additionally supported by the Institute for Clinical Evaluative Sciences (ices), which is funded by an annual grant from the mohltc. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ices or the Ontario mohltc is intended or should be inferred. Parts of this material are based on data and information provided by Cancer Care Ontario (cco). The opinions, results, views, and conclusions reported in this paper are those of the authors and do not necessarily reflect those of cco. No endorsement by cco is intended or should be inferred. Parts of this material are also based on data or information compiled and provided by the Canadian Institute for Health Information (cihi). However, the analyses, conclusions, opinions, and statements expressed in the material are those of the authors, and not necessarily those of cihi.
Publisher Copyright:
© 2018 Multimed Inc.
PY - 2018/10
Y1 - 2018/10
N2 - Background Gastrectomy with negative resection margins and adequate lymph node dissection is the cornerstone of curative treatment for gastric cancer (gc). However, gastrectomy is a complex and invasive operation with significant morbidity and mortality. Little is known about surgical practice patterns or short-and long-term outcomes in early-stage gc in Canada. Methods We undertook a population-based retrospective cohort study of patients with gc diagnosed between 1 April 2005 and 31 March 2008. Chart review provided clinical and operative details such as disease stage, primary tumour location, surgical approach, operation, lymph nodes, and resection margins. Administrative data provided patient demographics, geography, and vital status. Variations in treatment and outcomes were compared for 14 local health integration networks. Descriptive statistics and log-rank tests were used to examine geographic variation. Results We identified 722 patients with nonmetastatic resected gc. We documented significant provincial variation in case mix, including primary tumour location, stage at diagnosis, and tumour grade. Short-term surgical outcomes varied across the province. The percentage of patients with 15 or fewer lymph nodes removed and examined varied from 41.8% to 73.8% (p = 0.02), and the rate of positive surgical margins ranged from 15.2% to 50.0% (p = 0.002). The 30-day surgical mortality rates did not vary statistically significantly across the province (p = 0.13); however, rates ranged from 0% to 16.7%. Overall 5-year survival was 44% and ranged from 31% to 55% across the province. Conclusions This cohort of patients with resected stages i–iii gc is the largest analyzed in Canada, providing important historical information about treatment outcomes. Understanding the causes of regional variation will support interventions aiming to improve gc operative outcomes in the cancer system.
AB - Background Gastrectomy with negative resection margins and adequate lymph node dissection is the cornerstone of curative treatment for gastric cancer (gc). However, gastrectomy is a complex and invasive operation with significant morbidity and mortality. Little is known about surgical practice patterns or short-and long-term outcomes in early-stage gc in Canada. Methods We undertook a population-based retrospective cohort study of patients with gc diagnosed between 1 April 2005 and 31 March 2008. Chart review provided clinical and operative details such as disease stage, primary tumour location, surgical approach, operation, lymph nodes, and resection margins. Administrative data provided patient demographics, geography, and vital status. Variations in treatment and outcomes were compared for 14 local health integration networks. Descriptive statistics and log-rank tests were used to examine geographic variation. Results We identified 722 patients with nonmetastatic resected gc. We documented significant provincial variation in case mix, including primary tumour location, stage at diagnosis, and tumour grade. Short-term surgical outcomes varied across the province. The percentage of patients with 15 or fewer lymph nodes removed and examined varied from 41.8% to 73.8% (p = 0.02), and the rate of positive surgical margins ranged from 15.2% to 50.0% (p = 0.002). The 30-day surgical mortality rates did not vary statistically significantly across the province (p = 0.13); however, rates ranged from 0% to 16.7%. Overall 5-year survival was 44% and ranged from 31% to 55% across the province. Conclusions This cohort of patients with resected stages i–iii gc is the largest analyzed in Canada, providing important historical information about treatment outcomes. Understanding the causes of regional variation will support interventions aiming to improve gc operative outcomes in the cancer system.
UR - http://www.scopus.com/inward/record.url?scp=85056932448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056932448&partnerID=8YFLogxK
U2 - 10.3747/co.25.3953
DO - 10.3747/co.25.3953
M3 - Article
C2 - 30464695
AN - SCOPUS:85056932448
SN - 1198-0052
VL - 25
SP - e436-e443
JO - Current Oncology
JF - Current Oncology
IS - 5
ER -